Literature DB >> 21396216

Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia.

R Riquelme1, P Jiménez, A J Videla, H Lopez, J Chalmers, A Singanayagam, M Riquelme, P Peyrani, T Wiemken, G Arbo, G Benchetrit, M L Rioseco, K Ayesu, A Klotchko, L Marzoratti, M Raya, S Figueroa, F Saavedra, D Pryluka, C Inzunza, A Torres, P Alvare, P Fernandez, M Barros, Y Gomez, C Contreras, J Rello, J Bordon, C Feldman, F Arnold, R Nakamatsu, J Riquelme, F Blasi, S Aliberti, R Cosentini, G Lopardo, M Gnoni, T Welte, M Saad, J Guardiola, J Ramirez.   

Abstract

BACKGROUND: Community-acquired pneumonia (CAP) severity scores can identify patients at low risk for mortality who may be suitable for ambulatory care. Here, we follow the clinical course of hospitalized patients with CAP due to 2009 H1N1 influenza.
OBJECTIVE: To evaluate the role of CAP severity scores as predictors of mortality.
METHODS: This was a secondary data analysis of patients hospitalized with CAP due to 2009 H1N1 influenza confirmed by reverse transcriptase polymerase chain reaction enrolled in the CAPO (Community-Acquired Pneumonia Organization) international cohort study. CAP severity scores PSI (Pneumonia Severity Index), CURB-65 (confusion, urea, respiratory rate, blood pressure, age ≥ 65 years) and CRB-65 (confusion, respiratory rate, blood pressure, age ≥ 65 years) were calculated. Actual and predicted mortality rates were compared. A total of 37 predictor variables were evaluated to define those associated with mortality.
RESULTS: Data from 250 patients with CAP due to 2009 H1N1 influenza were analyzed. Patients with low predicted mortality rates (0-1.5%) had actual mortality rates ranging from 2.6% to 17.5%. Obesity and wheezing were the only novel variables associated with mortality.
CONCLUSIONS: The decision to hospitalize a patient with CAP due to 2009 H1N1 influenza should not be based on current CAP severity scores, as they underestimate mortality rates in a significant number of patients. Patients with obesity or wheezing should be considered at an increased risk for mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21396216     DOI: 10.5588/ijtld.10.0539

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  22 in total

1.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

2.  TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia.

Authors:  Erick J Rendón-Ramirez; Alejandro Ortiz-Stern; Corazon Martinez-Mejia; Mario C Salinas-Carmona; Adrian Rendon; Viviana L Mata-Tijerina; Adrian G Rosas-Taraco
Journal:  Viral Immunol       Date:  2015-04-29       Impact factor: 2.257

3.  How obesity impacts outcomes of infectious diseases.

Authors:  A Atamna; A Elis; E Gilady; L Gitter-Azulay; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-18       Impact factor: 3.267

Review 4.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Pulmonary cytokine composition differs in the setting of alcohol use disorders and cigarette smoking.

Authors:  Ellen L Burnham; Elizabeth J Kovacs; Christopher S Davis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-19       Impact factor: 5.464

6.  Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan.

Authors:  Koichiro Kudo; Jin Takasaki; Toshie Manabe; Hideko Uryu; Ritsuko Yamada; Emi Kuroda; Nobuyuki Kobayashi; Takeji Matsushita
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

7.  Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors.

Authors:  Miguel Delgado-Rodríguez; Jesús Castilla; Pere Godoy; Vicente Martín; Nuria Soldevila; Jordi Alonso; Jenaro Astray; Maretva Baricot; Rafael Cantón; Ady Castro; Fernando Gónzález-Candelas; José María Mayoral; José María Quintana; Tomás Pumarola; Sonia Tamames; Marc Sáez; Angela Domínguez
Journal:  J Antimicrob Chemother       Date:  2012-03-30       Impact factor: 5.790

8.  Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study.

Authors:  Claudine Angela Blum; Bettina Winzeler; Nicole Nigro; Philipp Schuetz; Silke Biethahn; Timo Kahles; Cornelia Mueller; Katharina Timper; Katharina Haaf; Janina Tepperberg; Margareth Amort; Andreas Huber; Roland Bingisser; Peter Stephan Sándor; Krassen Nedeltchev; Beat Müller; Mira Katan; Mirjam Christ-Crain
Journal:  J Headache Pain       Date:  2017-02-13       Impact factor: 7.277

9.  Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group.

Authors:  Deshayne B Fell; Eduardo Azziz-Baumgartner; Michael G Baker; Maneesh Batra; Julien Beauté; Philippe Beutels; Niranjan Bhat; Zulfiqar A Bhutta; Cheryl Cohen; Bremen De Mucio; Bradford D Gessner; Michael G Gravett; Mark A Katz; Marian Knight; Vernon J Lee; Mark Loeb; Johannes M Luteijn; Helen Marshall; Harish Nair; Kevin Pottie; Rehana A Salam; David A Savitz; Suzanne J Serruya; Becky Skidmore; Justin R Ortiz
Journal:  Vaccine       Date:  2017-09-01       Impact factor: 3.641

10.  Application of validated severity scores for pneumonia caused by SARS-CoV-2.

Authors:  Violeta Esteban Ronda; Sandra Ruiz Alcaraz; Paloma Ruiz Torregrosa; Mario Giménez Suau; Ester Nofuentes Pérez; José Manuel León Ramírez; Mariano Andrés; Óscar Moreno-Pérez; Alfredo Candela Blanes; Joan Gil Carbonell; Esperanza Merino de Lucas
Journal:  Med Clin (Engl Ed)       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.